Summary
Overview
Work History
Education
Skills
Accomplishments
Awards
Publications
Editoral board
Teaching Experience
Grant
Work Availability
Affiliations
Work Preference
Languages
Software
Timeline
background-images

Qixin Wang

Quincy,MA

Summary

I have conducted research with different focuses: (1) Molecular and cellular mechanism focused on pathway regulation and immune responses for chronic lung injury and inflammation (COPD and fibrosis) and infectious respiratory disease (Flu, Pneumonia, COVID and T.B.) (2). Antibody and RNA profiling and discovery for infectious disease prevention and vaccine development, such as flu, COVID-19, and pneumonia, via machine-learning-based analysis (R). (3). Developing and applying 3D engineered tissue as novel biological models for toxicity study, anti-fibrotic drug development, and fibrotic disease modeling. My career will focus on developing noninvasive treatments modeling for inflammatory diseases and airborne-based infections.

Overview

12
12
years of professional experience

Work History

Research Scientist/Research lead

Ragon Institute at MGH, MIT, and Harvard; and Harvard School of Public health, Department of immunology and infectious disease.
09.2023 - Current
  • Leading projects on applying system serology to understand the immune profile (antibody isotyping and antibody-dependent cellular functions) after different vaccination conditions and validating vaccine efficiency of against different pathogens via Luminex-flowcytometry based high-throughput analysis platform and R/pythol-based computational meta-data analysis pipeline.
  • Applying system serology approach in identifying and validating vaccines that designed to prevent the respiratory infections caused by flu, COVID, tuberculosis, and pneumococcus.
  • Lead project working with different consortiums from BWH, BIDMC, MGH, UCSD, and Scripps in investigating the profile of antibody isotyping and antibody-dependent cellular function and correlates of protection against most updated COVID and flu vaccines with concern variants.
  • Working as part of IMPAC-TB consortiums to understand the immune profile and potential correlates of protection of the Mtb vaccine current in clinical trial. Currently developing a new computation analysis pipeline to understand the temporal and compartment-specific correlates of protection after vaccination.
  • Investigate the immunogenicity after vaccination and provide scientific support for clinical trials conducted by companies and foundations.
  • Lead project working with Pfizer Inc. to determine the immunogenicity of different pneumococcal vaccine platforms throughout up to 3.5 years for elders from the clinical trial (NCT00427895), and determine the antibody profiles induced by different vaccine platforms (prime and booster) from various ages of individuals for pneumococcal vaccine.
  • Understanding the auto-antibody profiling association with Rheumatic Diseases.
  • Lead project working with BWH and MGH in investigating auto-antibody profile targeting different inflammatory chemokines and cytokines from individuals who currently: (1) suffer long COVID symptoms; (2) had symptoms before and cured; (3) are suffering Inflammatory rheumatism.
  • The System Serology lab moved from Ragon to Harvard School of Public Health in Nov 2024. All scientific projects, roles, and functions remain the same as in Ragon

Postdoctoral Associate

University of Rochester Medical Center, Department of Environmental Medicine.
09.2018 - 08.2023
  • Leading projects on 1). toxicology evaluation on different tobacco products; 2). Molecular and cellular mechanisms investigation focused on the molecular pathway regulation and immune responses on lung injury/inflammation/disease progression via 2D/3D in vitro, and in vivo models with knowledge in molecular/cellular biology, disease biology, tissue engineering and toxicology.
  • Discover new molecular and drug candidates for pulmonary fibrosis and COPD.
  • Lead project working on how Rev-erba agonist and antagonist in against COPD progression induced by cigarette smoke and bleomycin/flu virus induced lung fibrosis.
  • Understanding the potential molecular pathway regulated by Rev-erbd and other circadian clock molecules during fibrotic progression.
  • Discover new biomarkers for regulatory purposes and investigate airway inflammation and its potential prevention induced by tobacco products.
  • Lead project working on biomarkers discovery from human subjects through highthroughput platform for regulating different e-cig products, cooperating with the FDA for new policies on new e-cig regulation.
  • Lead project working on toxicology evaluation of different tobacco products: e-cigs, waterpipe smokes, cigarette smoke at acute and chronic term, on 2D and 3D cells, and animal models.
  • Lead project on pathology study how lung inflammation and injury progress related to e-cig and cigarette smoke exposure in acute and chronic terms.
  • Developing new 3D engineered tissue chips to perform high-throughput screening of inflammatory progression, wound healing interaction, and fibrotic potential of different e-cig products (grant awarded)

Research Associate (Graduate assistant)

University at Buffalo, Department of Biomedical Engineering.
09.2013 - 07.2018
  • Toxicity evaluation of nanomaterials (E.g. Carbon nanotube, Graphene Oxide, Nano Zerovalent Iron).
  • Cationic lipoplexes carried miRNA for lung fibrosis therapy.
  • Developing 3D microtissue array for toxicology evaluation and drug screening.

Education

Bachelor of Science - Biological Science and Engineering

University of Science and Technology Beijing
01.2013

Master of Science - Biomedical Engineering

University at Buffalo, the State University of New York
Buffalo, NY
01.2015

Doctor of Philosophy - Biomedical Engineering

University at Buffalo, the State University of New York
Buffalo, NY
01.2018

Skills

  • Scientific writing
  • Data analysis
  • Laboratory techniques
  • Paper writing
  • Technical troubleshooting
  • Method validation
  • Documentation expertise
  • Project Support
  • Research planning
  • Research methods
  • Results interpretation
  • Data analytics
  • Statistical modeling
  • Programming languages
  • Computational modeling
  • Image analysis
  • Research and publication
  • Experiment design
  • Experimental design
  • Research methodologies

Accomplishments

  • Designed in vitro and in vivo experiment for drug and biomarker candidate screening in various respiratory disease/injury models, with basic molecular, cellular and disease biology knowledge.
  • Achieved antibody discovering and characterization, and vaccine development by completing system serology and system biology under AI/ML model with accuracy and efficiency.
  • Collaborated with team members from Pfizer Inc. in the evaluation of vaccine efficacy of pneumococcal vaccine and determine the vaccine recommendations (Time and Strategies)
  • Discover arthritics biomarkers from long-COVID19 patient by introducing system-biology platform with help of AI/ML modeling.
  • Developed new ex vitro model for antibody discovery with shorter measurement period in a low-biosafety level and cell-free system compared to current methods.

Awards

2022 Abstract Scholarship, Assembly on Respiratory Cell and Molecular Biology (RCMB), ATS 2022 international conference, 2020 The 2nd place in poster presentation, CRoFT virtual annual meeting, 2020 Robert N. Infurna award for best scientific publication, 2017-2018 Teaching Assistant Scholarship, University at Buffalo, 2016 The 1st place in Poster presentation, Department of Biomedical Engineering, University at Buffalo, 2014-2018 Research Assistant Scholarship, The Research Foundation of SUNY, 2014-2015 Teaching Assistant Scholarship, University at Buffalo, 2012 Excellent internship award, Chinese Academy of Science, 2010 National Scholarship, University of Science & Technology Beijing

Publications

  • Wang, Q., Nag, D., Larsen, S., Baldwin, S., Coler, R., McNamara, RP., Antibodies as key mediators of protection against Mycobacterium tuberculosis. Frontiers in Immunology,15,1430955.
  • Tong X., Wang, Q., Chicz, TM., Blanc, R., Park, L., Barouch, D., McNamara, RP., Compartment-Specific Antibody Correlates of Protection to SARS-CoV-2 Omicron in Macaques. iScience: 110174.
  • Wang, Q., Blanc, R., Levine, K., Malca, H., Grant, L., Miller, A., Jelena V., Gessner, B., and Mcnamara, R., Conjugated pneumococcal vaccination yields broadly functional, mucosal-directed responses in aged adults (In preparation to Science Translation Medicine).
  • Wang, Q., Lucas, J.H., Pang, C., Zhao, R. and Rahman, I., Tobacco and menthol flavored nicotine-free electronic cigarettes induced inflammation and dysregulated repair in lung fibroblast and epithelium. Respiratory Research 25, no. 1 (2024): 1-11
  • Wang Q, Goracci C, Sundar IK, Rahman I. Environmental tobacco smoke exposure exaggerates bleomycin-induced collagen overexpression during pulmonary fibrogenesis. Journal of Inflammation, 21(1), pp.1-16.
  • Lucas JH, Wang Q, Pang C, Rahman I, (2024) Developmental perfluorooctane sulfonic acid exposure exacerbates house dust mite induced allergic responses in adult mice. Science of The Total Environment, 173768.
  • Lucas JH., Wang, Q., Atrash, J.M., Pang, C., and Rahman, I. Developmental PFOS Exposure has Sex-Dependent Effects on Lung Inflammation and Barrier Integrity in Juvenile Mice. Toxicological Sciences, 2024, kfae073, https://doi.org/10.1093/toxsci/kfae073
  • El Hellani A, Adeniji A, Erythropel HC, Wang Q, Lamb T, Mikheev VB, Rahman I, Stepanov I, Strongin RM, Wagener TL, Brinkman MC. Comparison of emissions across tobacco products: A slippery slope in tobacco control. Tobacco Induced Diseases. 2024 Mar 30;22(March):1-3. (white paper working with center for tobacco products (CTP) from FDA, and NIH).
  • Chandy M, Hill T 3rd, Jimenez-Tellez N, Wu JC, Sarles SE, Hensel E, Wang Q, Rahman I, Conklin DJ. Addressing Cardiovascular Toxicity Risk of Electronic Nicotine Delivery Systems in the Twenty-First Century: "What Are the Tools Needed for the Job?" and "Do We Have Them?". Cardiovasc. Toxicol. 2024 Mar 31:1-37. (white paper working with center for tobacco products (CTP) from FDA, and NIH).
  • Kassem N. O.F. Strongin R.M., Stroup A.M., Brinkman M.C., El-Hellani A, Erythropel H C., Etemadi A., Exil V, Goniewicz M.L., Kassem N.O., Klupinski T.P., Liles S, Muthumalage T, Noël A, Peyton D.H., Wang Q, Rahman I, Valerio L.G.,Jr. Generally Recognized as Safe (GRAS) Food Ingredients in E-cigarettes: A Toxicological Review. Nicotine and Tobacco Research (2024): ntae123. (white paper working with center for tobacco products (CTP) from FDA, and NIH).
  • Brinkman M.C., El-Hellani A, Erythropel H C., Exil V, Goniewicz M.L., Hansen E.G., Klupinski T.P., Li D., Luo W., Peyton D.H., Rahman I, Rezk-Hanna M., Strongin R.M., Stroup A.M., Wang Q.. Toxicity of waterpipe tobacco smoking: the role of flavors, sweeteners, humectants, and charcoal. Toxicological Sciences, 2024:, kfae095, https://doi.org/10.1093/toxsci/kfae095 (white paper working with center for tobacco products (CTP) from FDA, and NIH).
  • Wang Q, Sundar IK, Lucas JH, Park JG, Nogales A, Martinez-Sobrido L, Rahman I. Circadian clock molecule REV-ERBα regulates lung fibrotic progression through collagen stabilization. Nat Commun. 2023 Mar 9;14(1):1295.
  • Lucas JH, Wang Q, Rahman I. Perfluorooctane Sulfonic Acid Disrupts Protective Tight Junction Proteins via Protein Kinase D in Airway Epithelial Cells. Toxicol Sci. 2022;190(2):215-226. doi:10.1093/toxsci/kfac096
  • Giri A, Wang Q, Rahman I, Sundar IK. Circadian molecular clock disruption in chronic pulmonary diseases. Trends in Molecular Medicine. 2022 Jun 1;28(6):513-27. (Invited, cover highlighted).
  • Wang Q, Unwalla H, Rahman I. Dysregulation of mitochondrial complexes and dynamics by chronic cigarette smoke exposure Utilizing MitoQC reporter mice. Mitochondrion. 2022;63:43-50. doi:10.1016/j.mito.2022.01.003
  • Wang Q., Sundar, I. K., Lucas, J. H., Muthumalage, T., & Rahman, I. (2021). Molecular clock REV-ERBα regulates cigarette smoking-induced lung inflammation and epithelial-mesenchymal transition. JCI insight, 6(12), e145200. https://doi.org/10.1172/jci.insight.145200
  • Wang Q., Ji X.; Rahman, I., Dysregulated Metabolites Serve as Novel Biomarkers for Metabolic Diseases Caused by E-Cigarette Vaping and Cigarette Smoking. Metabolites 2021, 11 (6), 345.
  • Lucas JH, Wang Q, Muthumalage T, Rahman I. Multi-Walled Carbon Nanotubes (MWCNTs) Cause Cellular Senescence in TGF-β Stimulated Lung Epithelial Cells. Toxics. 2021; 9(6):144.
  • Sharma S, Wang Q, Muthumalage T, Rahman I. Epithelial Ablation of Miro1/Rhot1 GTPase Augments Lung Inflammation by Cigarette Smoke. Pathophysiology. 2021; 28(4):501-512.
  • Wang Q.; Sundar, I. K.; Li, D.; Lucas, J. H.; Muthumalage, T.; McDonough, S. R.; Rahman, I., E-cigarette-induced pulmonary inflammation and dysregulated repair are mediated by nAChR α7 receptor: role of nAChR α7 in SARS-CoV-2 Covid-19 ACE2 receptor regulation. Respiratory research 2020, 21 (1), 1-17.
  • Lucas JH, Wang Q, Muthumalage T, and Rahman I. Multi-Walled Carbon Nanotubes (MWCNTs) Cause Cellular Senescence in TGF-β Stimulated Lung Epithelial Cells. Toxics 9: 144, 2021.
  • Wang Q.; Sundar, I. K.; Blum, J. L.; Ratner, J. R.; Lucas, J. H.; Chuang, T.-D.; Wang, Y.; Liu, J.; Rehan, V. K.; Zeilfokk, J. T., Prenatal exposure to electronic-cigarette aerosols leads to sex-dependent pulmonary extracellular-matrix remodeling and myogenesis in offspring mice. American journal of respiratory cell and molecular biology 2020, 63 (6), 794-805. (Highlighted in current issue)
  • Muthumalage, T.; Lucas, J. H.; Wang, Q.; Lamb, T.; McGraw, M. D.; Rahman, I., Pulmonary Toxicity and Inflammatory Response of Vape Cartridges Containing Medium-Chain Triglycerides Oil and Vitamin E Acetate: Implications in the Pathogenesis of EVALI. Toxics 2020, 8 (3), 46.
  • Manevski, M.; Muthumalage, T.; Devadoss, D.; Sundar, I. K.; Wang, Q.; Singh, K. P.; Unwalla, H. J.; Chand, H. S.; Rahman, I., Cellular stress responses and dysfunctional Mitochondrial–cellular senescence, and therapeutics in chronic respiratory diseases. Redox Biology 2020, 33, 101443.
  • Lucas, J. H.; Muthumalage, T.; Wang, Q.; Friedman, M. R.; Friedman, A. E.; Rahman, I., E-Liquid containing a mixture of coconut, vanilla, and cookie flavors causes cellular senescence and dysregulated repair in pulmonary fibroblasts: implications on premature aging. Frontiers in Physiology 2020, 11.
  • Khan, N. A.; Lawyer, G.; McDonough, S.; Wang, Q.; Kassem, N. O.; Kas-Petrus, F.; Ye, D.; Singh, K. P.; Kassem, N. O.; Rahman, I., Systemic biomarkers of inflammation, oxidative stress and tissue injury and repair among waterpipe, cigarette and dual tobacco smokers. Tobacco control 2020, 29 (Suppl 2), s102-s109.
  • Wang Q.; Khan, N. A.; Muthumalage, T.; Lawyer, G. R.; McDonough, S. R.; Chuang, T. D.; Gong, M.; Sundar, I. K.; Rehan, V. K.; Rahman, I., Dysregulated repair and inflammatory responses by e-cigarette-derived inhaled nicotine and humectant propylene glycol in a sex-dependent manner in mouse lung. FASEB bioAdvances 2019, 1 (10), 609-623.
  • Lawyer, G. R.; Jackson, M.; Prinz, M.; Lamb, T.; Wang, Q.; Muthumalage, T.; Rahman, I., Classification of flavors in cigarillos and little cigars and their variable cellular and acellular oxidative and cytotoxic responses. PLoS one 2019, 14 (12), e0226066.
  • Khan, N. A., Yogeswaran, S., Wang, Q. Muthumalage, T.; Sundar, I. K.; Rahman, I., Waterpipe smoke and e-cigarette vapor differentially affect circadian molecular clock gene expression in mouse lungs. PLoS one 2019, 14 (2), e0211645. (Equal contribution)
  • Wang, Q.; Masud, A.; Aich, N.; Wu, Y., In vitro pulmonary toxicity of reduced graphene oxide-nano zero valent iron nanohybrids and comparison with parent nanomaterial attributes. ACS Sustainable Chemistry & Engineering 2018, 6 (10), 12797-12806.
  • Chen, Z., Wang, Q., Asmani, M.; Li, Y.; Liu, C.; Li, C.; Lippmann, J. M.; Wu, Y.; Zhao, R., Lung microtissue array to screen the fibrogenic potential of carbon nanotubes. Scientific reports 2016, 6 (1), 1-11.
  • Wang, Q; Wu, Y. MicroRNA Delivery by Lipoplexes in Lung Cancer Therapy. The World Scientific Encyclopedia of Nanomedicine and Bioengineering, Volume 3: Nanotechnology in Gene Delivery. Donglu Shi (Ed.), 2016. ISBN: 978-981-4667-65-4, World Scientific Publishers.
  • Luo H, Zhao H, Chang Y, Wang Q, Yu H, and Shen Z. Oriented Immobilization and Characterization of a Poly-Lysine-Tagged Cephalosporin C Acylase on Glyoxyl Agarose Support. Applied Biochemistry and Biotechnology 175: 2114-2123, 2015.
  • Wang, Q., Blanc, R., Levine, K., Malca, H., Grant, L., Miller, A., Gessner, B., and Mcnamara, R., Conjugated pneumococcal vaccination yields broadly functional, mucosal-directed responses in aged adults. Oral Presentation at 2024 Vaccine Summit at Boston (June 2024)
  • Wang, Q., Goracci, C., Sundar, I.K. and Rahman, I., 2023. Cigarette Smoke Exacerbates Bleomycin-induced Lung Injury and Collagen Deposition Via Lysyl Oxidase-dependent Mechanism in Mice. In B107. COPD: FROM OMICS TO TREATMENT (pp. A4410-A4410). American Thoracic Society.
  • Kaur, G., Tjitropranoto, A., Wang, Q., Shaikh, S.B. and Rahman, I., 2023. Lung Cellular Senescence Atlas by Single Cell RNA Sequencing and Other Biomarkers in Patients With COPD. In A107. AGING AND LUNG DISEASES COMING TO AGE (pp. A2661-A2661). American Thoracic Society.
  • Wang, Q., Park, J., Sundar, I. K., Lucas, J., Martinez-Sobrido, L., & Rahman, I. (2022). Molecular Clock Rev-erba Regulates Influenza A Virus-Induced Lung Fibrotic Progression via Collagen Stabilization. In B107. MOLECULAR MECHANISMS OF SARS-CoV-2, INFLUENZA, AND OTHER LUNG INFECTIONS (pp. A3607-A3607). American Thoracic Society. (Abstract Scholarship)
  • Q Wang, IK Sundar, I Rahman. Molecular Circadian Component REV-ERBα Regulates Pulmonary Inflammation Induced by Environmental Tobacco Smoke and Cigarette Smoke. TP109. TP109 COPD AND E-CIGARETTES: PRE-CLINICAL MODELS AND MECHANISMS, ATS annual meeting (2021)
  • J.H. Lucas, Q. Wang, and I. Rahman. Alterations in Lung Epithelial Barrier Integrity May Be Associated with Downregulation of AKT Signaling and Tight Junction Proteins by Perfluorooctane Sulfonic Acid (PFOS). SOT annual meeting (2021)
  • Q. Wang, JX Ji, and I. Rahman. Dysregulated Metabolites by Electronic Cigarette and Cigarette Smoke Serve as Novel Biomarker for Metabolic Diseases Caused by Vaping and Smoking. SOT annual meeting (2021)
  • S. Sharma, I. Sundar, R. K, Maremanda, Q. Wang, G. Kaur, T. Muthumalage, I. Rahman. Miro1 Regulates Mitochondrial Dysfunction and Inflammation by Cigarette Smoke and Environmental Tobacco Exposure in Lung Epithelium. SOT annual meeting (2021)
  • Q Wang, JG Park, IK Sundar, I Rahman. Molecular Circadian Component REV-ERBα Regulates Lung Inflammation Induced by Influenza Virus and Cigarette Smoke, B29. INFECTION AND IMMUNE INTERPLAY IN LUNG INJURY, ATS annual meeting (2020)
  • Q Wang, J Lucas, IK Sundar, I Rahman. Electronic-Cigarette Induces Dysregulated Repair Response and Extracellular Matrix Remodeling in Mouse Lung Via α7 Nicotinic Acetylcholine Receptor. D17. VAPING, CIGARETTES, AND LUNG INJURY, A6240-A6240, ATS annual meeting (2020)
  • Q Wang, IK Sundar, JL Blum, JR Ratner, JH Lucas, T-D Chuang, Y Wang, J Liu, VK Rehan, JT Zeilfokk, I Rahman. Prenatal E-cig Aerosol Exposure Leads to Extracellular Matrix Remodeling and Dysregulated Myogenesis in Offspring Mice with Sex-Dependent Manner. C25. EARLY LIFE EXPOSURES AS DETERMINANTS OF RESPIRATORY DISEASE, ATS annual meeting (2020)
  • N. Aich, Q. Wang, M. Arvid, N. Aich, Y. Wu. Interactions and Toxicity of Next Generation Graphene-Metal Nanohybrids at the Pulmonary Interfaces: Influence of Emerging Physicochemical Properties. Oral Presentation in 2018 American Institute of Chemical Engineers (AiChE) Annual Meeting, Pittsburgh, PA, USA.
  • Q. Wang, M. Arvid, N. Aich, Y. Wu. Effect of Metal Nanoparticle Conjugation on the Cytotoxicity of Graphene Oxides. Oral Presentation in 2017 SNO conference, Washington, DC, USA
  • Q. Wang, C. Liu and Y. Wu. MicroRNAs as Biomarkers for Cytotoxicity Evaluation of Multi-Wall Carbon Nanotube. Oral Presentation in 2015 American Institute of Chemical Engineers (AiChE) Annual Meeting, Salt Lake City, UT, USA.
  • Q. Wang, Z. Chen, C. Liu, R. Zhao and Y. Wu. A Microtissue Array Device to Evaluate Effects of Multiwall Carbon Nanotubes on Lung Tissue Mechanics and Pulmonary Toxicity. Oral Presentation in 2015 American Institute of Chemical Engineers (AiChE) Annual Meeting, Salt Lake City, UT, USA.
  • C. Liu, S. Shoemaker, T. Shaurova, Q. Wang, M. Petkovich, P. Hershberger, Y. Wu. Tumor-targeted Nanoparticles Deliver a Vitamin D-based Drug Payload for Treatment of EGFR Tyrosine Kinase Inhibitor-resistant Lung Cancer. Oral Presentation in 2016 Biomedical Engineering Society (BMES) Annual Meeting, Minneapolis, MN, USA.
  • C. Liu, Q. Wang, J. Spernyak, Y. Wu. MicroRNA Delivery by Multifunctional Lipoplexes in Lung Cancer Therapy and Imaging. Poster Presentation in Biomedical Engineering Society (BMES) Annual Meeting, Tampa, FL, USA.

Editoral board

  • Guest editor in Frontiers in Cell and Developmental Biology, Topics of Applications of Omics Technologies in Lung Research
  • Guest editor in Frontiers in Toxicology, Topics of Model Organisms in Clinical Toxicology

Teaching Experience

  • University at Buffalo, Department of Biomedical Engineering.
  • Principles of Biomedical Engineering. (University at Buffalo, 2014 Fall, Teaching assistant)
  • Biomedical Chemical Principles 2 (University at Buffalo, 2017 Fall Teaching assistant)
  • Biomaterials and Mechanics (University at Buffalo, 2015 Fall Teaching Assistant)

Grant

  • Name: Developing engineered tissue platform for screening the pro-fibrotic effects of flavored e-cigarettes (P.I.)
  • Funding: NIH/FDA Center for Research on Flavored Tobacco (CRoFT), Mentored Pilot Project
  • Duration: 09/01/2020-08/31/2021
  • Key personnel involved in research grants:
  • Molecular clock dysfunction in lung cellular senescence by environmental tobacco smoke
  • Funding: NIEHS (R01), PI: Irfan Rahman.
  • Duration: 05/01/2019-01/31/2024
  • Inflammatory and Dysregulated Repair Responses to Inhaled Nicotine
  • Funding: NHLBI (R01), PI: Irfan Rahman.
  • Duration: 01/16/2017-11/31/2021
  • Molecular Clock REV-ERBα in COPD and its exacerbations
  • Duration: 01/04/2017-2/28/2021
  • Mechanism of Mitochondrial Dysfunction in COPD
  • Duration: 07/01/2017-6/30/2021
  • Research Project 1: In vitro and in vivo assessment of flavorant toxicity in WNY Center for Research on Flavored Tobacco Products (CRoFT)
  • Funding: NCI (U54), P.I.: Irfan Rahman.
  • Duration: 09/14/2018-08/31/2023

Work Availability

monday
tuesday
wednesday
thursday
friday
saturday
sunday
morning
afternoon
evening
swipe to browse

Affiliations

  • Harvard School of Public Health

Work Preference

Work Type

Full TimePart Time

Work Location

On-SiteRemoteHybrid

Languages

English
Native or Bilingual
Chinese (Mandarin)
Native or Bilingual

Software

R

Microsoft

Graphpad

Timeline

Research Scientist/Research lead

Ragon Institute at MGH, MIT, and Harvard; and Harvard School of Public health, Department of immunology and infectious disease.
09.2023 - Current

Postdoctoral Associate

University of Rochester Medical Center, Department of Environmental Medicine.
09.2018 - 08.2023

Research Associate (Graduate assistant)

University at Buffalo, Department of Biomedical Engineering.
09.2013 - 07.2018

Bachelor of Science - Biological Science and Engineering

University of Science and Technology Beijing

Master of Science - Biomedical Engineering

University at Buffalo, the State University of New York

Doctor of Philosophy - Biomedical Engineering

University at Buffalo, the State University of New York